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Summary
 
A novel T cell–specific adaptor protein, RIBP, was identified based on its ability to bind Rlk/
Txk in a yeast two-hybrid screen of a mouse T cell lymphoma library. RIBP was also found to
interact with a related member of the Tec family of tyrosine kinases, Itk. Expression of
RIBP is restricted to T and natural killer cells and is upregulated substantially after T cell acti-
vation. RIBP-disrupted knockout mice displayed apparently normal T cell development. How-
ever, proliferation of RIBP-deficient T cells in response to T cell receptor (TCR)-mediated acti-
vation was significantly impaired. Furthermore, these activated T cells were defective in the
production of interleukin (IL)-2 and interferon 
 
g
 
, but not IL-4. These data suggest that RIBP
plays an important role in TCR-mediated signal transduction pathways and that its binding to
Itk and Rlk/Txk may regulate T cell differentiation.
Key words: T cell activation • signal transduction • adaptor protein • Tec tyrosine kinases • 
T helper type 1/T helper type 2 cells
 
I
 
t is well established that T cell activation critically depends
on signal transduction pathways mediated by protein ty-
rosine kinases (PTKs)
 
1
 
 of the Src (Fyn and Lck) and Syk
(Syk and ZAP-70) families (1–4). In contrast, the biological
functions of members of the Tec family of tyrosine kinases
are not well understood, nor have the biochemical mecha-
nisms by which they operate been elucidated. These kinases
contain a Src homology (SH)3 domain capable of binding
proline-rich sequences, an SH2 domain capable of binding
phosphotyrosine-containing sequences, and a tyrosine ki-
nase domain (5, 6). However, unlike other Src family ki-
nases, members of the Tec family characteristically lack a
negative regulatory tyrosine residue at the COOH termi-
nus (7–9), whose dephosphorylation is normally required
for kinase activity.
Multiple members of the Tec subfamily have been iden-
tified in T cells and B cells, including Itk, Rlk/Txk, Btk,
and Tec. Itk, a 72-kD IL-2–inducible PTK expressed in T
cells and NK cells (9, 10), has been reported to be involved
in T cell activation. Mice deficient in Itk display deficits in
both T cell development and peripheral T cell activation
(11); these T cells exhibit a diminished intracellular Ca
 
2
 
1
 
flux in response to TCR/CD3 signaling, and consistent
with this, reduced phospholipase C
 
g
 
-1 phosphorylation
and inositol triphosphate production (12). Additionally, Itk
has been implicated in CD28 signal transduction, although
whether it functions to positively or negatively regulate this
pathway is unclear (13–15). Tec is expressed in multiple
hematopoietic and nonhematopoietic cell types, including
T cells (16, 17). Although a recent report suggests that it
may function in antigen receptor signal transduction in T
cells (18), other evidence suggests that Tec is involved in
signaling through receptors for the cytokines IL-3, IL-6,
and GM-CSF (19–21, respectively). Finally, we identified
previously a novel member of the Tec subfamily of Src-
related PTKs, Rlk (also called Txk), that is expressed pri-
marily in T cells, mast cells, and testes (22, 23). Unlike
other Tec subfamily members, Rlk (a 62-kD protein) lacks
an NH
 
2
 
-terminal pleckstrin homology domain, and its ex-
pression is downregulated in naive T cells after activation.
Moreover, there is substantially more Rlk expressed in Th1-
 
1
 
Abbreviations used in this paper:
 
 ES, embryonic stem; KO, knockout;
PRR, proline-rich region; PTB, phosphotyrosine-binding; PTK, protein
tyrosine kinase; RAG, recombinase-activating gene; RIBP, Rlk/Itk-
binding protein; SH, Src homology; TBST, Tris-buffered saline/Tween.
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type than Th2-type cells (22), suggesting that it may be in-
volved in T cell differentiation. Although one recent study
implicates Rlk in the binding of the cytoplasmic tail of the
counter-costimulatory receptor CTLA-4 (24), little is known
about the biochemical targets of this PTK or its possible
functions in T cell activation.
To begin to elucidate the function(s) of Rlk and related
Tec kinases, we sought to identify associated proteins using
the yeast two-hybrid system for analyzing interprotein in-
teractions. A unique cDNA clone was identified that inter-
acted with both Rlk and Itk. This cDNA encodes a puta-
tive adaptor protein, termed RIBP (for Rlk/Itk-binding
protein). RIBP mRNA is expressed in T cells and NK cells
and is significantly upregulated after T cell activation. Fi-
nally, targeted disruption of the RIBP gene via homologous
recombination was shown to inhibit TCR/CD3-induced
T cell proliferation, and IL-2 and IFN-
 
g
 
 production, but
not IL-4 production. Together these data suggest that this
novel molecule may provide an important adaptor function
for Tec subfamily kinases critically involved in T cell acti-
vation and differentiation.
 
Materials and Methods
 
Bait cDNA Cloning and Yeast Two-Hybrid cDNA Library Screen.
 
The Y153 
 
Saccharomyces cerevisiae
 
 strain (auxotrophic for adenine,
uracil, leucine, and tryptophan) as well as the bait and trap expres-
sion vectors, pAS1 and pACT, respectively, have been described
(25). The Rlk and Itk chimeric bait constructs were generated by
cloning full-length cDNA, PCR-amplified using primers encoding
NcoI and BamHI sites, into the NcoI and BamHI sites in the mul-
tiple cloning site of pAS1. The Itk cDNA in pcDNA1 (Invitrogen)
was a gift of Dan Littman (New York University, New York,
NY). A mouse T cell lymphoma MATCHMAKER cDNA library
in pACT (Clontech) was screened using the Rlk bait as per the
manufacturer’s protocol. Full-length clones were identified by
screening a custom-made Uni-ZAP mouse day 16 fetal thymic
cDNA library (Stratagene) using a cDNA probe derived from the
positive yeast clone, 2.3.2.
 
293 Cell Culture and Transfections.
 
Human embryonic kidney
HEK293 cells were maintained in DMEM (GIBCO BRL) sup-
plemented with 10% FCS, penicillin/streptomycin (100 
 
m
 
g/ml),
and 2-ME. RIBP-HA cDNA was generated by cloning full-
length (the short form) RIBP cDNA into pcDNA3 (Invitrogen)
modified by ligation of a double-stranded oligonucleotide encod-
ing a Kozak sequence and an HA tag between its HindIII and
NotI sites (a gift from the laboratory of Harinder Singh, Univer-
sity of Chicago), between NotI and XbaI sites. Lck cDNA in the
PEF expression vector was obtained from the laboratory of David
Straus (University of Chicago). Transient transfections were
carried out using a standard calcium phosphate precipitation
method. Medium was exchanged 24 h after transfection, and cells
were harvested 48 h after transfection.
 
Immunoprecipitation and Immunoblotting Analysis.
 
HEK293 cells
were harvested and lysed in 1 ml of lysis buffer (0.5% Triton X-100,
50 mM Tris [pH 7.4], 150 mM NaCl, 5 mM EDTA [pH 8.0],
1 mM sodium vanadate, 10 
 
m
 
g/ml leupeptin, 10 
 
m
 
M aprotinin,
1 mM PMSF). Aliquots of the lysates (400 
 
m
 
g) were precleared at
4
 
8
 
C with 50 
 
m
 
l of protein G–agarose beads (GIBCO BRL) coated
with 2.5 
 
m
 
g of rat IgG (Southern Biotechnology Associates). Im-
munoprecipitations were performed by incubating the precleared
lysate with 50 
 
m
 
l of protein G–agarose beads precoated with 2.5 
 
m
 
g
of rat high-affinity anti-HA Ab (Roche Diagnostics). Preclears
and immunoprecipitates were washed four times in lysis buffer. All
steps were performed at 4
 
8
 
C. The preclears and immunoprecipi-
tates were boiled in 50 
 
m
 
l of 2
 
3
 
 reducing SDS sample buffer and
subjected to SDS-PAGE on a 10% gel. Proteins were subse-
quently transferred to a polyvinyldifluoride membrane preblocked
in a 10% nonfat milk/1
 
3
 
 TBST (Tris-buffered saline/Tween:
10 mM Tris, 150 mM NaCl, 0.05% Tween-20) solution. Blots
were probed with a rabbit polyclonal anti-Itk antiserum (a gift
from the laboratory of Dan Littman) solution (1:5,000 dilution in
5% nonfat milk/TBST) and developed with a 1:8,000 diluted
anti–rabbit Ig (Amersham Pharmacia Biotech). For anti-RIBP
immunoblotting, a rabbit polyclonal anti-RIBP antiserum solu-
tion (1:1,000 dilution in 2% nonfat milk/TBST) was used to
probe blots.
 
Chromosomal Localization of the Mouse RIBP Gene.
 
The RIBP
gene was mapped by Southern blot analyses of two sets of multilo-
cus crosses: (NFS/N or C58/J 
 
3
 
 
 
Mus musculus musculus
 
) 
 
3
 
 
 
M
 
.
 
 m
 
.
 
musculus
 
 and (NFS/N 
 
3
 
 
 
Mus spretus
 
) 
 
3
 
 
 
M
 
.
 
 spretus
 
 or C58/J. Off-
spring of these crosses have been previously typed for 
 
.
 
1,200
loci distributed over the 19 autosomes and the X chromosome (26,
27). Recombinational distances were calculated according to Green
(28), and gene order was established by minimizing the number
of recombinants.
 
Northern and Southern Blot Analysis.
 
For Northern blot analy-
sis, total RNA was isolated from the indicated tissues and cell types
using TRIzol (GIBCO BRL) according to the manufacturer’s
protocol or as described previously (23). Northern blots were
probed for the presence of RIBP mRNA using 
 
32
 
P-labeled cDNA
probes derived from either full-length RIBP or RIBP 1–208
(encoding RIBP from the NH
 
2
 
 terminus to the end of the SH2
domain) by random priming, using a Prime-It II kit (Stratagene).
The RIBP transcript was detected as a band 
 
z
 
1.7 kb in size, mi-
grating faster than the 18S rRNA band.
For Southern blot analysis, genomic DNA was prepared from
embryonic stem (ES) cell clones by standard methods, and digested
with the indicated restriction endonucleases. The DNA was de-
natured and, after gel electrophoresis and membrane transfer, hy-
bridized to either a 5
 
9
 
 or 3
 
9
 
 
 
32
 
P-labeled RIBP cDNA probe (as
indicated in the text, and see Fig. 4 B). Bands representing either
the endogenous or targeted RIBP allele were detected based on
size, as described in the text and in the legend to Fig. 4 B.
 
Targeted Deletion of the RIBP Gene and Generation of RIBP-defi-
cient Mice.
 
The targeting construct was electroporated into the
R1 ES cell line, derived from the 129/Sv mouse strain, using
standard techniques (29). Homologous recombination at the RIBP
locus was detected by Southern blot analysis using 5
 
9
 
 and 3
 
9
 
 probes
binding outside the RIBP regions used in the targeting construct
(see above, and Fig. 4 B). Targeted ES cell clones were used for
blastocyst injection, and the resulting chimeric animals were back-
crossed to C57BL/6 mice. Agouti offspring carrying the targeted
RIBP allele were interbred to generate progeny homozygous for the
targeted RIBP allele. Progeny were typed by Southern blot analysis
of tail genomic DNA (see Fig. 4 B), and subsequently, by PCR anal-
ysis, using primer pairs which either amplified endogenous sequence
between exons 2 and 3 or sequences in the 
 
neo
 
 cassette.
 
Flow Cytofluorimetric Analyses.
 
Single cell suspensions from
thymi, lymph nodes, and spleens were prepared according to
standard methods. Cells were then blocked with an anti-F
 
c
 
R
mAb, 2.4G2, and stained with the Abs indicated in the text. Abs
used in these experiments were conjugated to biotin or one of the
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following fluorochromes: FITC, PE, or Cy-Chrome. Ab-stained
cells were analyzed on a FACScan™ (Becton Dickinson) flow
cytometer.
 
Proliferation Assays.
 
Whole lymph node cells, splenocytes, or
a 1:1 mixture of lymph node or splenic T cells cultured with T
cell–depleted, irradiated syngeneic splenic APCs, from wild-type
(either progeny from heterozygous intercrosses or [C57BL/6 
 
3
 
129] F2 mice; The Jackson Laboratory), heterozygous, or homozy-
gous knockout (KO) mice were used in these experiments. Solu-
ble anti-CD3
 
e
 
 mAb (145-2C11) with or without soluble anti-
CD28 mAb (PV-1) was added to wells of round-bottomed 96-well
plates (Costar) at the concentrations indicated in the text. When
used, final concentrations of PMA and ionomycin were 10 ng/ml
and 0.5 
 
m
 
M, respectively. Cells (2 
 
3
 
 10
 
5
 
) were added to each
well at a final concentration of 1 
 
3
 
 10
 
6
 
/ml and cultured at 37
 
8
 
C
in DMEM supplemented with 10% FCS, penicillin/streptomycin
(100 
 
m
 
g/ml), and 2-ME. After 40 h, individual wells were pulsed
with [
 
3
 
H]thymidine (1 
 
m
 
Ci/well) for 8 h, for a total duration of
48 h of stimulation. Cell contents were then harvested onto fiber-
glass filters, scintillation fluid was added (25 
 
m
 
l/well), and counts
were determined using a TopCount microplate scintillation counter
(Packard).
 
IL-2 ELISAs.
 
IL-2 ELISAs were performed on culture su-
pernatants of activated cell cultures (described above). Nunc-
Immuno plates (Nalge Nunc) were used for these assays. Plates were
coated with an anti–IL-2 coating Ab overnight at 4
 
8
 
C, washed,
and blocked in 2% BSA/PBS for 1 h at room temperature. Su-
pernatants, diluted in 2% BSA/PBS, were incubated on the coated
plates overnight at 4
 
8
 
C. The next day, plates were washed, then
incubated with an anti–IL-2 detecting Ab for 1 h at room tem-
perature. Plates were washed and incubated with a 1:5,000 dilu-
tion of streptavidin-horseradish peroxidase (Zymed), after which
they were developed using TMB One-Step Substrate (Dako).
Abs and IL-2 standards were all purchased from Endogen.
 
RNase Protection Assays.
 
Splenocytes from wild-type (either
[C57BL/6 
 
3
 
 129] F2 described above, or when indicated,
C57BL/6 mice), heterozygous, and homozygous KO mice were
activated with the indicated concentrations of soluble anti-CD3
mAb with or without anti-CD28. At the indicated times, cells
were harvested, and RNA was prepared as described above. Cyto-
kine RNase protection assays were performed using the Ribo-
Quant Multi-Probe RNase Protection Assay System (PharMin-
gen) according to the manufacturer’s protocol. In brief, a 
 
32
 
P-labeled
RNA probe was synthesized via in vitro transcription from the
mCK-1 plasmid template. Aliquots of 2.5 
 
m
 
g of total RNA per
sample were hybridized overnight at 56
 
8
 
C to the probe. Samples
were then digested with RNase A, after which they were treated
with Proteinase K and phenol/chloroform extracted. Samples
were then precipitated, resuspended in 1
 
3
 
 loading buffer, heated
briefly at 90
 
8
 
C, and subjected to electrophoresis on a 5% denatur-
ing polyacrylamide gel. Gels were dried, and autoradiography
was performed. Densitometry on the cytokine and housekeeping
gene bands was performed using a Molecular Dynamics Image-
Quant
 
®
 
 densitometer.
 
Results
 
RIBP Is a Novel Adaptor Protein That Interacts with Rlk and
Itk.
 
The yeast two-hybrid system of detecting interpro-
tein interactions was used to identify potential Rlk-binding
proteins that might mediate or regulate Tec family kinase
function. A cDNA encoding full-length Rlk was cloned
 
into a yeast vector encoding the GAL4 DNA-binding do-
main, thus yielding a “bait” fusion protein consisting of
Rlk physically linked to this DNA-binding protein. A
mouse T cell lymphoma cDNA library was screened using
the Rlk bait. This library consisted of “trap” cDNAs cloned
into a yeast vector encoding the GAL4 transactivation do-
main. The T cell cDNA library was chosen as Rlk is highly
expressed both in the thymus and in peripheral T cells. Two
specificity criteria were used as measures of GAL4-mediated
transcriptional activation: (a) histidine synthesis by the yeast,
and (b) 
 
b
 
-galactosidase synthesis. A total of 750,000 yeast
colonies were screened. 86 of these colonies were identi-
fied as positive for bait–trap interaction by the first pass cri-
terion of growth on histidine-deficient (His
 
2
 
) medium sup-
plemented with 3-aminotriazole, an inhibitor of weak
endogenous histidine synthesis. Among the 86 colonies, 56
were positive for interaction with the Rlk bait fusion pro-
tein based on the second criterion of 
 
b
 
-galactosidase syn-
thesis (blue/white selection). The cDNA library plasmids
isolated from the 
 
b
 
-galactosidase–positive yeast colonies
were subsequently transformed into bacteria to distinguish
multiple trap cDNAs present within the same yeast colony
during the original screening. A total of 65 unique cDNA
clones were identified and subsequently retransformed into
yeast. One clone, 2.3.2, was found to interact with Rlk with
high specificity, and was chosen for further study.
Initial sequence analysis demonstrated that clone 2.3.2
did not represent a full-length cDNA; consequently, a
mouse fetal thymic cDNA library was screened using a probe
derived from the positive yeast cDNA clone. This screen
yielded a full-length cDNA that was used to examine inter-
actions with Rlk and Itk. Yeast transformed with the full-
length cDNA, termed RIBP, interacted specifically with
both Rlk and Itk (Fig. 1 A, bottom; nos. 2 and 6, respec-
tively). We further examined whether the interaction of
RIBP
 
 
 
with Rlk depended on the kinase function of Rlk.
An altered Rlk that contained a point mutation in the ki-
nase domain (K309
 
fi
 
R, denoted K309R) previously shown
to abolish kinase activity (our unpublished observations)
was incapable of binding RIBP (Fig. 1 A, bottom; no. 4).
This suggests that the bait–trap interaction is critically de-
pendent on the functionality and activity of the tyrosine ki-
nase domain of Rlk.
Human epithelial kidney (HEK293) cells were transfected
transiently with constructs encoding HA-tagged RIBP
and/or Itk to directly examine protein–protein interactions
in mammalian cells. Cell lysates were immunoprecipitated
with an anti-HA Ab, resolved by SDS-PAGE, and sub-
jected to immunoblotting using an anti-Itk antiserum. As
shown in Fig. 1 B, a specific interaction between RIBP and
Itk was detected (top panel, lane 5). Coexpression of the
Src family kinase, Lck, increased the amount of Itk copre-
cipitated with RIBP (Fig. 1 B, top; compare lane 6 with
lane 5). This Lck-dependent augmentation of RIBP–Itk
complex formation was not due to increased levels of Itk in
the cell lysates or RIBP-HA in the immunoprecipitates
(Fig. 1 B, top, lane 2 vs. lane 1; and bottom, lane 6 vs. lane
5, respectively). The results suggested that the interaction
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of RIBP with Itk is regulated, at least in part, by Src family
kinase–specific phosphorylation of one or both proteins.
 
Structural Analysis and Chromosomal Location of RIBP.
 
Sequence and genomic analyses were performed on the RIBP
gene product. RIBP contains an SH2 domain (highly ho-
mologous to the SH2 domain of Shc, 47% [data not shown]),
a proline-rich region (PRR) capable of binding SH3 do-
mains, and an NPIY substrate sequence for binding by phos-
photyrosine-binding (PTB) domains (30) present within
the PRR (Fig. 1 C). Further analysis of the cDNA library
identified a second RIBP transcript that represented an
alternatively spliced form with an 8 amino acid sequence
insert (VWASQQKA). Other potentially significant amino
acid sequences within RIBP include two YXXP motifs,
implicated in binding the SH2 domains of rasGAP, Abl,
and Crk (31), and one YXXV motif, potentially capable of
binding the SH2 domain of the tyrosine phosphatase, SHP-2
(32). Additionally, RIBP contains three potential sites for
 
N
 
-myristoylation (Fig. 1 C). These structural features and
the absence of a catalytic domain suggest that RIBP func-
tions as an adaptor protein. One adaptor protein, TSAd
(33), showed extensive sequence homology to RIBP. The
human TSAd protein exhibits a 68% sequence identity and
a 76% sequence similarity with RIBP. The sequence ho-
Figure 1. Identification of an Rlk and Itk interacting protein, RIBP. (A) Yeast two-hybrid system interactions between RIBP and Itk, Rlk, or kinase-
mutant Rlk (K309R). Top: Growth of bait plus trap–transformed yeast on leucine and tryptophan–deficient (2LT) medium (positive control for trans-
formation with both constructs). Bottom: Assay for a specific bait–trap interaction. Growth of bait plus trap–transformed yeast on –LT, 13-aminotriazole
(3AT, endogenous histidine synthesis inhibitor) medium. For interactions with Rlk, results are representative of 11 independent experiments. For inter-
actions with Itk, results are representative of two independent experiments. For interactions with Rlk(K309R), results are representative of four indepen-
dent experiments. (B) Western blot demonstrating association of RIBP with Itk in transfected HEK293 cells. Top: Lysates prepared from HEK293 cells
transfected with the indicated constructs (top of the blot) were precleared with rat IgG on protein G beads, and subsequently, the supernatants were im-
munoprecipitated with rat anti-HA mAb. Immunoprecipitates and preclears were resolved by SDS-PAGE, transferred to a polyvinyldifluoride mem-
brane, and immunoblotted with an anti-Itk antiserum. Bottom: Immunoblot from B was stripped and reprobed with mouse anti-HA to assess the
amount of RIBP in the immunoprecipitates. Results are representative of three experiments. WCL, whole cell lysates. (C) Amino acid sequence homol-
ogy between RIBP and TSAd. NH2 and COOH termini of a putative SH2 domain and PRR are indicated by arrows. Dots between amino acids in
RIBP and TSAd indicate homology, with two dots indicating greater homology. The amino acid insertions present in the alternatively spliced forms of
RIBP and TSAd are boxed with a solid line; NPXY PTB domain sequences are underlined, and YXXP and YXXV sequences, in boldface, are in boxes
with dashed lines or dot-dashed lines, respectively. Putative N-myristoylation sites are in boldface and italics. The RIBP nucleotide sequence is available
from EMBL/GenBank/DDBJ under accession no. AF203343.
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mology between RIBP and TSAd was greatest within the
SH2 domain, where the two proteins share an 87% sequence
identity (80/92 amino acids; Fig. 1 C). Furthermore, TSAd
exists in two alternatively spliced forms, similar to RIBP,
with a 10 amino acid insert present in the longer form. Al-
though these results suggested that RIBP and TSAd may be
species homologues, the sequence insertions in RIBP and
TSAd are in different locations within the molecules. The
10 amino acid insertion in TSAd is located within the SH2
domain, whereas the 8 amino acid insertion in RIBP is lo-
cated within one of the exons in the region between the
SH2 domain and the PRR (Fig. 1 C).
Genomic linkage studies of the RIBP gene were per-
formed by Southern blot analyses of two sets of multilocus
crosses (described in Materials and Methods). Digestion of
DNA samples from parental mice with HindIII produced
RIBP fragments of 8.6 and 2.9 kb in 
 
M
 
.
 
 spretus 
 
and 11.0
and 10.8 kb in NFS/N. BamHI produced fragments of
12.4 and 4.0 kb in NFS/N and 16.5 kb in 
 
M
 
.
 
 m
 
.
 
 musculus
 
.
Inheritance of the variant fragments was compared with
that of other markers previously typed in these crosses.
The RIBP locus was mapped to mouse chromosome 3
(Fig. 2). Closest linkage was detected with 
 
Gba
 
, for which
no recombinants were detected in 171 mice, indicating
that the genes are within 1.7 cM of one another at the up-
per limit of the 95% confidence interval. Similarly, no re-
combination was detected with 
 
Lmna
 
 in 103 mice, placing
RIBP within 2.9 cM of Lmna. The RIBP gene maps to a
region of mouse chromosome 3 with conserved synteny to
human chromosome 1q21 (34, 35), where both human
GBA (36) and LMNA (37), as well as TSAd (33) and Shc
(38), are located. Thus, the RIBP gene has a genomic lo-
calization congruent with that of the TSAd and Shc genes,
supporting the possibility of gene duplication events in this
region.
RIBP Is Restricted in Expression to T Lymphocytes and NK
Cells. Tec family members have been shown to have re-
stricted tissue expression. In the cases of Rlk and Itk, ex-
pression is largely restricted to T cells, with Itk also expressed
in NK cells and Rlk also expressed in mast cells. Northern
blot analyses were performed on RNA samples isolated
from various tissues in order to examine the tissue expres-
sion of RIBP. A 1.7-kb transcript representing RIBP was
expressed in the thymus, lymph node, and to a lesser ex-
tent, in the spleen and bone marrow (Fig. 3 A, left panel,
lane 5; right panel, lanes 1 and 2; and left panel, lanes 4 and 3,
respectively). In addition, analysis of multiple hematopoietic
cell lines revealed that RIBP was expressed in T cell lines
(e.g., BW.P and C57), but not expressed in a B cell lym-
phoma, A20, or a mastocytoma, P815 (data not shown).
Northern blot analyses of thymocyte subpopulations dem-
onstrated that RIBP mRNA was expressed in CD41CD81
thymocytes (Fig. 3 A; right panel, lane 5), and in both CD41
and CD81 peripheral T cells (Fig. 3 A, right panel, lanes 4
and 3, respectively). Additionally, although RIBP was ex-
pressed in TCR2 thymocytes (Fig. 3 A, right panel, lane 6),
little expression was detected in recombinase-activating
gene (RAG)-2–deficient thymus (Fig. 3 A, right panel,
lane 7). These data suggest that RIBP expression may be de-
pendent on signal transduction through the pre-TCR, and
consequently, that its expression levels vary during the course
of T cell development.
RIBP mRNA was found to be rapidly induced after T
cell activation (Fig. 3 B, top panel). RIBP expression was
upregulated in the Th1 T cell clone, A.E7, in as little as 2 h
after exposure to anti-CD3 (Fig. 3 B, top left panel). Simi-
larly, RIBP mRNA was induced in another Th1 T cell
clone, pGL10, when activated with anti-CD3 (Fig. 3 B,
top right panel) or ovalbumin in the presence of appropri-
ate APCs (data not shown). The addition of exogenous
IL-2 had no effect on RIBP expression, although it signifi-
cantly increased [3H]thymidine incorporation (Fig. 3 B, top
right panel, and data not shown). In addition to T lympho-
cytes, NK cells stimulated with IL-2 were observed to ex-
press high levels of RIBP mRNA (Fig. 3 B, bottom panel).
Furthermore, RIBP was also expressed in the Th2 clones
PL104 and PL3, as also shown in Fig. 3 B (bottom panel).
Generation of RIBP-deficient Mice. RIBP KO mice were
generated by disrupting the RIBP gene via homologous re-
combination. A targeting construct was generated that re-
placed exons 3 and 4 (encoding the SH2 domain) with a
DNA segment encoding a neo gene. The targeting construct,
depicted in Fig. 4 A, was introduced into the R1 ES cell
line derived from the 129/Sv mouse strain. Southern blot
analyses of drug-resistant ES cells demonstrated successful
targeted disruption at the RIBP locus (Fig. 4 B, top). Ge-
nomic DNA samples from control and targeted ES cells
were digested with EcoRI and XhoI, resolved by gel elec-
trophoresis, and hybridized to a 59 RIBP cDNA probe. As
seen in Fig. 4 B (top left panel), probing of control digested
ES cell DNA revealed bands of the predicted size (3.8 kb).
Figure 2. Chromosomal localization of mouse RIBP. To the right of
the map are recombination fractions between adjacent loci, with the first
fraction representing data from the M. m. musculus crosses and the second
from the M. spretus crosses. Numbers in parentheses are recombinational
distances 6 SE. The M. m. musculus crosses were not typed for D3Mit22.
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In contrast, DNA from targeted ES cell clones revealed bands
migrating at 5.5 kb, consistent with the replacement of the
third and fourth exons with the neo cassette. Similar results
were observed using a 39 RIBP cDNA probe of control
versus targeted ES cell genomic DNA samples digested
with Asp718 (an isoschizomer of KpnI) and XhoI (Fig. 4 B,
top right panel). The neomycin-resistant ES cells (clone 2)
were injected into C57BL/6 blastocysts using standard
techniques (29). Chimeric mice were bred to C57BL/6
mice to establish germline transmission, and heterozygous
mice were interbred to obtain homozygous KO progeny.
Southern blot analyses performed on tail genomic DNA
samples from the progeny demonstrated successful targeted
disruption at the RIBP locus (Fig. 4 B, bottom panel). Ini-
tial studies revealed that homozygous KO mice lacked
RIBP mRNA expression based on Northern blot analyses
(data not shown). The lack of RIBP expression in the
RIBP KO offspring was confirmed by immunoblot analy-
ses using an RIBP-specific polyclonal antiserum. As seen in
Fig. 4 C, lysates from wild-type C57BL/6 and heterozygous
splenocytes activated with anti-CD3 contained significant
amounts of RIBP protein migrating at z46 kD. In con-
trast, no RIBP protein was detected in activated T cells
from homozygous RIBP-deficient animals.
Analyses of Thymic and Peripheral T Cell Populations in
RIBP-deficient Mice. RIBP KO mice did not display any
gross developmental abnormalities, and a normal Mende-
lian distribution of RIBP KO progeny was observed. The
percentages of CD42CD82, CD41CD81, CD41CD82,
and CD42CD81 thymocytes did not differ between RIBP
KO and wild-type (Fig. 5 A) or heterozygous (data not
shown) control mice, and no significant qualitative or quan-
titative differences in lymph node and splenic T cell popu-
lations were evident (Fig. 5 B, and data not shown, respec-
tively). In addition, the CD41/CD81 ratio in both lymph
node (Fig. 5 B) and spleen (data not shown) was similar
among the various groups. Moreover, no obvious differ-
ences in the sizes or cell yields of thymus, spleen, and lymph
nodes isolated from RIBP KO mice were apparent com-
pared with wild-type control mice (data not shown). These
data suggest that RIBP does not have an essential role in T cell
development or homeostasis of peripheral T cell populations.
Proliferative Responses of RIBP-deficient T Cells in Response
to TCR Ligation Are Impaired. Given the findings that (a)
RIBP expression is augmented by T cell activation, and (b)
its binding partners Itk and Rlk have been shown to be
requisite for T cell responses to activation stimuli (11, 39),
studies to evaluate the functional status of RIBP KO T cells
were undertaken. In response to TCR/CD3-mediated sig-
nals delivered by an anti-CD3 mAb, proliferation of RIBP
KO T cells was considerably reduced relative to control T
cell proliferation (Fig. 6 A). This proliferative impairment
was observed across the range of anti-CD3 concentrations
tested, and ranged from an 80% reduction in proliferation
at the lowest (anti-CD3 concentration) to a 50% reduction
in proliferation at the highest (anti-CD3 concentrations).
Although RIBP KO T cells displayed an apparent defect in
TCR-mediated T cell activation, they were capable of re-
ceiving CD28-mediated costimulation (Fig. 6 A). These
data indicate that RIBP KO T cells are impaired in their
ability to respond to TCR-mediated signals, whereas respon-
siveness to CD28 signals is less affected.
To determine whether the RIBP KO T cells were de-
fective in either proximal or distal components of the TCR
signaling pathway, RIBP KO T cells were treated with ei-
ther anti-CD3 or PMA and ionomycin, and proliferation
Figure 3. Northern blot analysis of RIBP tissue and
T cell subset expression and its induction by T cell acti-
vation. (A) Northern blot analysis of RIBP gene ex-
pression in various tissues, and in different thymocyte
subsets and peripheral T cells. A blot with RNA from
various tissues was probed with an oligonucleotide de-
rived from RIBP cDNA (left). Reprobing of the blot
with an oligonucleotide specific for the housekeeping
gene EF demonstrated equivalent RNA loading (not
shown). RIBP expression in lymph node and thy-
mocyte subsets was assessed similarly (right). Ethidium
bromide staining of the gel revealed equivalent RNA
loading except for lanes 3 and 4 (not shown), which
had greater amounts of RNA present. (B) Northern
blot analysis of regulation of RIBP gene expression by
T cell activation. Top: RIBP expression in A.E7 Th1
T cell clones (left) and PGL10 Th1 T cell clones (right)
stimulated with anti-CD3 (0.1 mg/ml for A.E7, and
5.0 mg/ml for PGL10) for the indicated times. Total
RNA per sample was assessed by ethidium bromide
staining, and demonstrated equivalent loading (not
shown). Results for regulation of RIBP expression in
T cell clones are representative of a total of four exper-
iments. Bottom: Expression of RIBP in NK cells and
Th2 T cell clones.
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was compared with that of wild-type T cells activated with
the same stimuli. As shown in Fig. 6 B, RIBP KO T cell
proliferation in response to anti-CD3 was 50% reduced
compared with wild-type T cells. However, wild-type and
RIBP KO T cells stimulated with PMA and ionomycin
proliferated equivalently, suggesting that the inadequacy in
TCR-mediated signaling in RIBP KO T cells lies upstream
of pathways triggered by protein kinase C activation or in-
tracellular Ca21 flux. These findings are consistent with those
reported for T cells deficient in either Itk (11) or both Itk
and Rlk (39).
Reduced Cytokine Production by Activated RIBP KO T Cells.
RIBP KO splenocytes were stimulated with anti-CD3 and
examined for cytokine production. Consistent with the re-
duced proliferative response (Fig. 6, A and B), a significant
reduction in the amount of IL-2 in the culture supernatant
was observed (Fig. 6 C). Furthermore, although CD28-medi-
ated costimulation increased IL-2 production by both wild-
type and KO T cells, the relative differences in IL-2 levels
were maintained. These results were confirmed using an
RNase protection assay to determine relative levels of IL-2
transcripts in activated RIBP KO versus wild-type T cells.
As shown in Fig. 6 D, IL-2 mRNA was detected at 6 h in
(C57BL/6 3 129) F2 wild-type T cells stimulated with
anti-CD3. In contrast, little IL-2 mRNA was apparent in
activated RIBP KO T cells at this time point (Fig. 6 D,
lane 5 versus lane 4). Densitometry analyses revealed that
IL-2 mRNA levels in RIBP KO T cells were reduced by
z80% relative to wild-type cells (data not shown). Also,
consistent with the reduction in supernatant levels of IL-2
(Fig. 6 C), the relative amounts of IL-2 mRNA from
RIBP KO T cells activated with anti-CD3 and anti-CD28
were still significantly reduced compared with control T cells
(Fig. 6 D, lane 7 versus lane 6).
In addition to a reduction in IL-2 levels, a pronounced
decrease in IFN-g production was observed in RIBP KO
T cells (Fig. 7 A). As was the case for IL-2, this reduction
in IFN-g production correlated with decreased IFN-g
mRNA levels (Fig. 7 B), suggesting that RIBP affects lym-
phokine production at the level of transcription and/or
mRNA stabilization. Little IFN-g mRNA was observed in
anti-CD3–activated RIBP KO T cells relative to wild-type
T cells; densitometry revealed that this was a .90% reduc-
tion (Fig. 7 B; densitometry data not shown). However,
anti-CD28 costimulation did restore the IFN-g decrease
observed in RIBP KO T cells, suggesting that this defect
may be an indirect consequence of the reduced activation
and IL-2 production. Finally, despite the reductions in IL-2
Figure 4. Targeted disruption of the
RIBP gene. (A) Partial restriction endonu-
clease maps of the endogenous RIBP locus,
targeting construct, and the targeted RIBP
locus. Top: Restriction endonuclease map
of the endogenous RIBP locus. Exons 3 and
4, deleted by homologous recombination in
the KO mice, are indicated. Middle: Re-
striction endonuclease map of the targeting
construct. Bottom: Restriction endonu-
clease map of the targeted RIBP locus. (B)
Southern blot analyses of genomic DNA
from targeted ES cell clones and genotyping
of a litter from an intercross of RIBP het-
erozygous parents. Top left: Genomic DNA
from ES cell clones was digested with
EcoRI and XhoI, subjected to gel electro-
phoresis, and subsequently hybridized to a 59
RIBP cDNA probe (a 1.8-kb fragment
spanning the 59-most EcoRI site to the
KpnI/Asp718 site). The wild-type RIBP al-
lele is represented by a 3.8-kb band, and the
targeted allele is represented by a 5.5-kb
band. Targeted ES cell clones are lanes 1–4,
and a wild-type ES cell clone is denoted J1.
Top right: ES cell genomic DNA was di-
gested with Asp718 and XhoI, subjected to
gel electrophoresis, and subsequently hy-
bridized to a 39 RIBP cDNA probe (a 1-kb
fragment contained within the SmaI to Hind-
III fragment, near the 39 end of RIBP, as
shown in A). The wild-type RIBP allele is
represented by a 20-kb band, and the tar-
geted allele is represented by a 15-kb band.
ES cell clones are as indicated previously.
Bottom: Mouse tail genomic DNA samples from progeny of a mating of RIBP heterozygous parents were digested, subjected to gel electrophoresis, and
subsequently hybridized to a 59 RIBP cDNA probe as described previously for ES cell clone samples (top left). (C) Verification of absence of RIBP ex-
pression in RIBP KO mice. Lysates were prepared from activated splenocytes from wild-type, heterozygous, and homozygous KO mice and immuno-
blotted with an anti-RIBP polyclonal antiserum.
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and IFN-g production by RIBP KO T cells, no significant
reduction in IL-4 production was observed (Fig. 7 C). In
fact, in some experiments, activated RIBP KO splenocytes
produced more IL-4 than did control splenocytes. Thus,
the lack of RIBP appears to more profoundly affect the
ability of T cells to produce Th1-type cytokines than Th2-
type cytokines.
Discussion
In this study, a yeast two-hybrid T cell cDNA library
screen was used to search for proteins that could associate
with the T cell–specific members of the Tec family of ty-
rosine kinases, Rlk and Itk. A novel adaptor molecule,
termed RIBP, was identified that interacts with a site in
Rlk and Itk regulated by tyrosine phosphorylation. RIBP is
expressed in thymocytes, and at low levels in resting pe-
ripheral T cells. Expression of RIBP is upregulated after T
cell activation, coinciding with the expression levels of one
of its binding partners, Itk, and high expression levels are
observed in activated NK cells. The restriction of RIBP
expression to T cells and NK cells mirrors the expression
patterns of several signaling molecules, including Itk (9),
linker for activation of T cells (LAT [40]), which is also ex-
pressed in mast cells, and ZAP-70 (41). These results are
consistent with the proposed common lineage of these cells
(42). Finally, genetic disruption of RIBP was found to sig-
nificantly impair TCR/CD3-mediated proliferation, and
IL-2 and IFN-g production, although IL-4 production was
unaffected. Furthermore, the TCR-mediated signal trans-
duction defects observed in RIBP KO T cells were bypassed
using the downstream mitogens, PMA and ionomycin.
These results suggest that RIBP positively regulates TCR
signaling by acting as a molecular link between Itk/Rlk
and other components of the TCR signaling pathway. The
consequences of this interaction include the regulation of
TCR-mediated signal transduction, and consequently, lym-
phokine production.
RIBP is a complex adaptor protein. The gene encodes a
PRR that may bind SH3 domain–containing proteins such
as other Src family kinases and other adaptor proteins. In
addition, a tyrosine-phosphorylated NPIY sequence present
in RIBP may bind PTB domain–containing proteins such
as Shc. Proteins such as Shc have been implicated in TCR
signal transduction via interactions with ZAP-70 (43) and
Cbl, an adaptor which is thought to negatively regulate
ZAP-70 activation (44, 45) and binds to the SH3 domain
of Itk. The tyrosine-based protein binding motifs present in
RIBP (YXXP and YXXV) may bind the SH2 domains of
rasGAP, Abl, Crk, and SHP-2, molecules previously shown
to regulate T cell signal transduction. Finally, RIBP con-
tains an SH2 domain that may be involved in binding to
other phosphotyrosine-containing proteins. In this regard,
preliminary results indicate that the SH2 domain of RIBP
is required for interaction with Rlk, whereas the PRR and
tyrosine-based protein binding motifs are unnecessary (our
unpublished observations).
The molecular mechanisms that link RIBP, Rlk, and Itk,
to the proximal event of TCR ligation are unclear. The
finding that Lck coexpression augments the association of
RIBP with Itk is consistent with a role for RIBP in the
regulation of TCR signal transduction. Tyrosine phosphor-
ylation of Itk, catalyzed by Lck or Fyn, is required for opti-
mal Itk kinase activity (46, 47), and consequently, T cell
activation. Phosphorylation of Itk occurs at Y511, a residue
in the activation loop of the kinase domain of Itk (48).
Thus, RIBP could be functionally coupled to TCR en-
gagement, as its binding to Itk is enhanced by the activity
of this CD4/CD8 coreceptor–associated Src family kinase
in vitro.
RIBP may bind to both Itk and Rlk, raising the question
as to its physiological partner and the relationship of its bind-
ing specificity to the functional deficit evident in RIBP KO
T cells. The expression pattern of RIBP suggests that its
physiological binding partner may be Itk in the periphery.
Previous studies have shown that Rlk is highly expressed in
resting T cells, but downregulated after T cell activation. In
Figure 5. Flow cytofluorimetric analysis of T cell development and pe-
ripheral T cell subsets in RIBP KO mice. (A) Thymocyte development in
RIBP KO mice. Mice used were 7–10 wk of age. Cells were stained with
FITC-conjugated anti-CD8 mAb and PE-conjugated anti-CD4 mAb to
distinguish double negative, double positive, and single positive popula-
tions. Staining of thymocytes pooled from three wild-type mice (WT,
left) compared with thymocytes pooled from three RIBP KO mice
(right). (B) Lymph node T cell subsets in RIBP KO mice. Lymph node
cells from 7–10 wk old wild-type (left) and KO (right) mice were stained
with the same Abs as in A, as described in Materials and Methods. Results
are representative of four independent experiments.
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Figure 6. Impairment of RIBP KO T cell proliferation and
IL-2 production in response to TCR-triggered activation. (A)
Proliferation of T cells from RIBP heterozygous and RIBP
KO mice as a function of TCR stimulus (anti-CD3). Spleno-
cytes from heterozygous (filled symbols) or KO (open symbols)
mice were stimulated with the indicated concentrations of soluble anti-CD3 alone (triangles), with or without soluble anti-CD28 added at 1.0 mg/ml
(circles). Proliferation was assessed at 48 h, with a [3H]thymidine pulse added after 40 h, for an 8-h pulse duration. Results are representative of four in-
dependent experiments performed using splenocytes, and three independent experiments using purified T cells and irradiated, T cell–depleted APCs. (B)
Proliferation of T cells from wild-type (WT) and RIBP KO mice in response to either anti-CD3 or PMA plus ionomycin (P1I). Proliferation was as-
sessed as above. (C) Splenocytes from wild-type and RIBP KO mice were stimulated with 1 mg/ml of soluble anti-CD3, with or without 1 mg/ml of
soluble anti-CD28. Supernatants were collected at either 6, 24, or 48 h, and the concentration of IL-2 was determined by ELISA; values listed above
were obtained at 24 h. Results are representative of 11 independent experiments. (D) Splenocytes from RIBP KO or wild-type mice were activated for
the indicated times with anti-CD3 with or without anti-CD28. Ab concentrations were 1 mg/ml for both mAbs. RNA prepared from cells was subse-
quently subjected to RNase protection assays, as described in Materials and Methods. 32P autoradiogram of RNase protection assay polyacrylamide gel.
Top: IL-2 mRNA levels in wild-type and RIBP KO T cells activated for the indicated times with the stimuli listed. EL4 mRNA is a positive control for
cytokine gene expression, and yeast tRNA is a negative control. Bottom: mRNA levels for the L32 housekeeping gene. Results are representative of three
independent experiments.
contrast, Itk gene expression is upregulated after T cell acti-
vation, similar to RIBP. Furthermore, the phenotype ob-
served in RIBP KO T cells more closely resembles the
phenotype of Itk-deficient T cells, which display dimin-
ished proliferation and IL-2 production in response to TCR
ligation. In contrast, Rlk KO T cells have only minor defi-
cits in TCR-mediated T cell activation (39). However,
there are circumstances when the binding of RIBP to Rlk
may be physiologically relevant. For instance, both RIBP
and Rlk are expressed in thymocytes. Although we have
not identified any profound changes in T cell development
in the RIBP KO or Rlk KO mice (our unpublished obser-
vations, and reference 39, respectively), there may be sub-
tle, as yet unidentified effects of this interaction in the thy-
mus. Moreover, both Rlk and RIBP are expressed in NK
cells, and may play a role in this lymphocyte subset. In
fact, recent evidence indicates that Itk and Rlk have over-
lapping functions in T cell activation, as mice deficient in
both kinases have more severely diminished peripheral T
cell function than mice deficient in either kinase alone (39).
Thus, further biochemical and breeding studies to gener-
ate RIBP/Itk and RIBP/Rlk double-KO mice will be
needed in order to determine the differential effects of
RIBP on the functions of Itk versus Rlk. It is important to
emphasize that the functional impairment present in RIBP
KO T cells was not as severe as that observed in Rlk/Itk
double-KO T cells. There are two possible reasons for these
findings. First, there may be functional homologues of RIBP
that can partially compensate for the absence of RIBP in
KO T cells. Second, not all of the intracellular effects on
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TCR signaling that Rlk and Itk mediate may require RIBP
or any putative homologues.
The fact that CD28-mediated costimulation partially
compensates for the severely diminished proliferative re-
sponse to TCR/CD3-mediated T cell activation in RIBP
KO mice (Fig. 6 A) suggests that the RIBP KO T cells are
capable of responding to the CD28-mediated costimula-
tory signal. Interestingly, Itk has been reported to be both a
positive and negative regulator of CD28-mediated T cell
activation. On the one hand, Itk is physically associated with
CD28 after T cell activation (49), and Jurkat T cells ex-
pressing CD28 cytoplasmic tail mutants incapable of re-
cruiting Itk are suppressed in their ability to produce IL-2.
However, Littman and colleagues demonstrated that T cells
from Itk-deficient mice were hyperresponsive to CD28
costimulation (15). Therefore, it remains to be determined
in what context, if any, RIBP is involved in CD28 signal
transduction.
Finally, the results of this study support a role for RIBP
in the regulation of Th cell subset differentiation. IL-2 and
IFN-g production were both significantly reduced in acti-
vated RIBP KO T cells (Figs. 6 and 7), whereas IL-4 pro-
duction was unaffected (Fig. 7 C). Such a selective impair-
ment in IFN-g and IL-2 production suggests that RIBP
may act in signaling pathways that promote Th1 differentia-
tion. The lack of RIBP may reduce TCR-mediated signal
strength via impairment of Itk and/or Rlk function, result-
ing in a selective loss of Th1 differentiation, as suggested by
Bottomly and colleagues (50). This may occur by generat-
ing decreased TCR signals that drive Th2 skewing. In fact,
both Itk and Rlk have been implicated in T cell differenti-
ation (Schaeffer, E., personal communication). Also, Rlk is
selectively expressed in Th1-type T cells. These results may
explain, at least in part, the finding that RIBP selectively
affects Th1-type cytokine production.
In conclusion, we have identified and functionally char-
acterized a novel T cell adaptor molecule involved in the
regulation of responses to T cell activation stimuli, specifi-
cally proliferation and lymphokine production. This adap-
tor, RIBP, appears to function in TCR/CD3-mediated
signal transduction, consistent with previously reported
data regarding its binding partners, the Tec tyrosine kinases
Rlk and Itk. The binding of RIBP to Itk and Rlk may pro-
vide important biochemical links of these two important
kinases with other components in the T cell activation ma-
chinery. Further molecular studies will be needed to deter-
mine the specific sites of action of RIBP within various T
cell signal transduction pathways.
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Figure 7. Demonstration of defective IFN-g induction and normal IL-4 induction by activated RIBP KO T cells.
(A) ELISA determination (see Fig. 6 C) of IFN-g production by RIBP KO T cells. Results are representative of at
least three independent experiments. (B) 32P autoradiogram of RNase protection assay polyacrylamide gel, as described
in the legend to Fig. 6 D. Stimulation conditions are also as described for Fig. 6 D. Top: IFN-g mRNA levels in wild-
type (WT) and RIBP KO T cells activated for the indicated times with the stimuli listed. EL4 mRNA is a positive
control for cytokine gene expression, and yeast tRNA is a negative control. Bottom: mRNA levels for the L32 house-
keeping gene. Results are representative of three independent experiments. (C) IL-4 production by activated control
and RIBP KO T cells. Supernatants (see Figs. 6 C and 7 A) were collected at 48 h and assessed for IL-4 by ELISA.
Results are representative of at least three independent experiments.
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